Lilly starts the trend to limit 340B pricing to contract pharmacies

Lilly starts the trend to limit 340B pricing to contract pharmacies. Other drug manufacturers follow including Sanofi, Merck, AstraZeneca, United Therapeutics, Novartis, Novo Nordisk

See the limited distribution letter attached.